SUBSCRIBE
SUBSCRIBE
Genetown

Anika Therapeutics Enrolls First Patient in U.S. Clinical Study for Monovisc™

January 8, 2008 | 
1 min read

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has enrolled the first patient in a multi-center study evaluating its single-injection osteoarthritis product, MONOVISC™.

MORE ON THIS TOPIC
Job Trends
Massachusetts’ Life Sciences Job Growth Slows, but 10-Year Outlook Remains Strong: Report
June 12, 2024
 · 
4 min read
 · 
Angela Gabriel
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
Pictured: Man holding tablet computer with scienti
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
 · 
3 min read
 · 
Greg Slabodkin
Pictured: Collage of Sarepta Therapeutics, DNA, and an IV bag
FDA
Sarepta Seeks Label Expansion, Bigger Market for DMD Gene Therapy
May 7, 2024
 · 
4 min read
 · 
Tyler Patchen